Steph & CO Edwards Lifesciences Corp Transaction History

Steph & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$69.28 - $93.38 $6,235 - $8,404	-90 Reduced 33.58%	178 $12,000
Q4 2022 Jan 26, 2023	BUY	$68.3 - $87.44 $3,141 - $4,022	46 Added 20.72%	268 $20,000
Q2 2022 Jul 13, 2022	BUY	$86.5 - $128.27 $1,730 - $2,565	20 Added 9.9%	222 $21,000
Q1 2022 Apr 15, 2022	SELL	$101.96 - $128.34 $4,078 - $5,133	-40 Reduced 16.53%	202 $24,000
Q2 2021 Jul 27, 2021	SELL	$83.84 - $104.76 $1,006 - $1,257	-12 Reduced 4.72%	242 $25,000
Q1 2021 Apr 16, 2021	BUY	$78.68 - $90.67 $944 - $1,088	12 Added 4.96%	254 $21,000
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $8,803 - $11,773	153 Added 171.91%	242 $17,000
Q4 2019 Feb 24, 2020	BUY	$71.7 - $82.09 $6,381 - $7,306	89 New	89 $21,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

Stay updated on Steph & CO with notifications on news.